Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
09:43am, Wednesday, 03'rd Jun 2026
/PRNewswire/ -- Компания Amgen (NASDAQ: AMGN) сегодня объявила, что Европейская комиссия (ЕК) выдала регистрационное удостов�
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
09:00am, Wednesday, 03'rd Jun 2026
New Phase 3 MITIGATE Open-Label Extension Data Support the Long-Term Safety Profile and Sustained Results of UPLIZNA ® in IgG4-RD Real-World Evidence Supports TAVNEOS ® Efficacy and Safety Profile w
Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication
12:15pm, Tuesday, 02'nd Jun 2026
AMGN wins EU approval for Imdylltra in extensive-stage small cell lung cancer after phase III data showed a 40% reduction in death risk.
Here's Why Amgen (AMGN) is a Strong Momentum Stock
10:51am, Monday, 01'st Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
04:01pm, Friday, 29'th May 2026
THOUSAND OAKS, Calif., May 29, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:55 a.m.
This Boring Income Portfolio Strategy Could Unlock 300%+ Upside
11:45am, Wednesday, 27'th May 2026
Most people think you can't time the market. That's nonsense.
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?
11:37am, Wednesday, 27'th May 2026
NVO and AMGN square off as GLP-1 leadership, pipeline depth and diversification shape a compelling healthcare stock comparison.
Ember LifeSciences announces new strategic investments boosting Series A to $27M
09:00am, Wednesday, 27'th May 2026
LOS ANGELES, May 27, 2026 /PRNewswire/ -- Ember LifeSciences, Inc., ("Ember") a leading provider of revolutionary cold chain technology, today announced strategic investments from Amgen Ventures, th
130 Years of the Dow: Why It Still Matters for Advisors
04:37pm, Tuesday, 26'th May 2026
On May 26, 1896, Charles Dow calculated a simple arithmetic average of 12 industrial stocks and arrived at a closing value of 40.94. Now, exactly 130 years later, that same benchmark has crossed the h
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits?
10:25am, Tuesday, 26'th May 2026
Amgen faces LOE headwinds and pricing pressure, yet key growth drugs and biosimilars continue gaining traction.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 26'th May 2026
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Amgen's Growth Engine Is Just Getting Started
09:45am, Tuesday, 26'th May 2026
Amgen delivers consistent, market-beating returns, supported by a robust growth portfolio and prudent capital allocation. AMGN's pipeline strength is evident, with 16 drugs on track for blockbuster st
AMGN Fairly Valued by DCF at $292
07:48am, Tuesday, 26'th May 2026
On May 26, 2026, we delve into the discounted cash flow (DCF) analysis for Amgen Inc (AMGN), a biopharmaceutical company that has shown a solid price performanc
The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.
Amgen says CFO Peter Griffith to retire, names Dittrich as successor
05:20pm, Tuesday, 19'th May 2026
Amgen said on Tuesday its chief financial officer, Peter Griffith, would retire, with Thomas Dittrich taking over the role in September.
